Gaëtan Garraux

Gaëtan Garraux

Auto-generated profile, based on publicly available information

Gaëtan Garraux

Neurology Department, University Hospital of Liège, B-4000 Liège, Belgium

Research Focus & Metrics

Academic Career Length

31Years (1996-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 August 2010 in Annals of Neurology
Verified
Journal Article
Closed access
PDF file
RVRik Vandenberghe
Rik Vandenberghe
KLKoen Van Laere
Koen Van Laere
AIAdrian Ivanoiu
Adrian Ivanoiu
ESEric Salmon
Eric Salmon
CBChristine Bastin
Christine Bastin
DBDavid Brooks
David Brooks

6 March 2006 in Brain
Verified
Journal Article
Open access
PDF file
SBStephan Bohlhalter
Stephan Bohlhalter
AGA. Goldfine
A. Goldfine
SMS. Matteson
S. Matteson
GGG. Garraux
G. Garraux
THT. Hanakawa
T. Hanakawa
MHMark Hallett
Mark Hallett
Little is known about the neural correlates of tics and associated urges. In the present study, we aimed to explore the neural basis of tics in patients with Tourette syndrome by using event-related functional MRI (fMRI). Ten patients (6 women, 4 men; age: mean ± SD = 31 ± 11.2) were studied while spontaneously exhibiting a variety of motor and vocal tics. On the basis of synchronized video/audio recordings, fMRI activities were analysed 2 s before and at tic onset irrespective of the clinical phenomenology. We identified a brain network of paralimbic areas such as anterior cingulate and insular cortex, supplementary motor area (SMA) and parietal operculum (PO) predominantly activated before tic onset (P < 0.05, corrected for multiple comparisons). In contrast, at the beginning of tic action, significant fMRI activities were found in sensorimotor areas including superior parietal lobule bilaterally and cerebellum. The results of this study indicate that paralimbic and sensory association areas are critically implicated in tic generation, similar to movements triggered internally by unpleasant sensations, as has been shown for pain or itching.

26 April 2004 in Annals of Neurology
Verified
Journal Article
Closed access
PDF file
GGGaëtan Garraux
Gaëtan Garraux
ABAndrew Bauer
Andrew Bauer
THTakashi Hanakawa
Takashi Hanakawa
TWTao Wu
Tao Wu
KKKenji Kansaku
Kenji Kansaku
MHMark Hallett
Mark Hallett

24 October 2005 in Human Brain Mapping
Verified
Journal Article
Closed access
PDF file
ESEric Salmon
Eric Salmon
DPDaniela Perani
Daniela Perani
KHKarl Herholz
Karl Herholz
PMPatricia Marique
Patricia Marique
EKElke Kalbe
Elke Kalbe
GGGaëtan Garraux
Gaëtan Garraux

14 August 2012 in Neurology
Verified
Journal Article
Closed access
PDF file
MSManu Sharma
Manu Sharma
JIJohn P.A. Ioannidis
John P.A. Ioannidis
JAJan O. Aasly
Jan O. Aasly
GAGrazia Annesi
Grazia Annesi
ABAlexis Brice
Alexis Brice
RKRejko Krüger
Rejko Krüger
Objective: Eleven genetic loci have reached genome-wide significance in a recent meta-analysis of genome-wide association studies in Parkinson disease (PD) based on populations of Caucasian descent. The extent to which these genetic effects are consistent across different populations is unknown. Methods: Investigators from the Genetic Epidemiology of Parkinson9s Disease Consortium were invited to participate in the study. A total of 11 SNPs were genotyped in 8,750 cases and 8,955 controls. Fixed as well as random effects models were used to provide the summary risk estimates for these variants. We evaluated between-study heterogeneity and heterogeneity between populations of different ancestry. Results: In the overall analysis, single nucleotide polymorphisms (SNPs) in 9 loci showed significant associations with protective per-allele odds ratios of 0.78–0.87 (LAMP3, BST1, and MAPT) and susceptibility per-allele odds ratios of 1.14–1.43 (STK39, GAK, SNCA, LRRK2, SYT11, and HIP1R). For 5 of the 9 replicated SNPs there was nominally significant between-site heterogeneity in the effect sizes (I2 estimates ranged from 39% to 48%). Subgroup analysis by ethnicity showed significantly stronger effects for the BST1 (rs11724635) in Asian vs Caucasian populations and similar effects for SNCA, LRRK2, LAMP3, HIP1R, and STK39 in Asian and Caucasian populations, while MAPT rs2942168 and SYT11 rs34372695 were monomorphic in the Asian population, highlighting the role of population-specific heterogeneity in PD. Conclusion: Our study allows insight to understand the distribution of newly identified genetic factors contributing to PD and shows that large-scale evaluation in diverse populations is important to understand the role of population-specific heterogeneity. Neurology® 2012;79:659–667

1 January 2014 in NeuroImage: Clinical
Verified
Journal Article
Open access
QNQuentin Noirhomme
Quentin Noirhomme
DLDamien Lesenfants
Damien Lesenfants
FGFrancisco Gomez
Francisco Gomez
ASAndrea Soddu
Andrea Soddu
JSJessica Schrouff
Jessica Schrouff
SLSteven Laureys
Steven Laureys
Multivariate classification is used in neuroimaging studies to infer brain activation or in medical applications to infer diagnosis. Their results are often assessed through either a binomial or a permutation test. Here, we simulated classification results of generated random data to assess the influence of the cross-validation scheme on the significance of results. Distributions built from classification of random data with cross-validation did not follow the binomial distribution. The binomial test is therefore not adapted. On the contrary, the permutation test was unaffected by the cross-validation scheme. The influence of the cross-validation was further illustrated on real-data from a brain-computer interface experiment in patients with disorders of consciousness and from an fMRI study on patients with Parkinson disease. Three out of 16 patients with disorders of consciousness had significant accuracy on binomial testing, but only one showed significant accuracy using permutation testing. In the fMRI experiment, the mental imagery of gait could discriminate significantly between idiopathic Parkinson's disease patients and healthy subjects according to the permutation test but not according to the binomial test. Hence, binomial testing could lead to biased estimation of significance and false positive or negative results. In our view, permutation testing is thus recommended for clinical application of classification with cross-validation.